Option Care CHRO awarded 9,579 restricted shares

Option Care Health, Inc. Chief Human Resources Officer Michael Bavaro reported two equity transactions.

Rhea-AI Filing Summary

Option Care Health, Inc. Chief Human Resources Officer Michael Bavaro reported two equity transactions. He acquired 9,579 shares of common stock as a restricted stock unit award at a stated price of $0.00 per share. These units vest in three equal annual installments beginning on the first anniversary of the grant date.

He also disposed of 551 shares of common stock at $35.24 per share in a tax-withholding transaction used to satisfy obligations associated with equity compensation. After these transactions, his directly held common stock balance reported in the filing increased compared with prior holdings.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Bavaro Michael

Role Chief Human Resources Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,579	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	551	$35.24	$19K

Holdings After Transaction: Common Stock — 54,002 shares (Direct)

Footnotes (1)

1. F1. The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Option Care Health (OPCH) insider Michael Bavaro acquire in this Form 4?

Michael Bavaro received an award covering 9,579 shares of Option Care Health common stock at a stated price of $0.00 per share. The filing describes this as a restricted stock unit grant with vesting over three years in equal annual installments.

How do the new restricted stock units for OPCH’s CHRO vest over time?

The restricted stock units granted to the CHRO vest in three stages. One third of the underlying common shares vests on each of the first, second, and third anniversaries of the grant date, spreading the ownership benefits over a multi-year period.

What disposition of Option Care Health (OPCH) shares did the Form 4 report?

The Form 4 reports that 551 shares of Option Care Health common stock were disposed of at $35.24 per share. The transaction is characterized as a tax-withholding disposition used to pay exercise price or tax liabilities related to equity compensation.

Was the 551-share OPCH disposition an open market sale by Michael Bavaro?

The 551-share transaction is coded as a tax-withholding disposition rather than an open market sale. The filing explains it was used to pay the exercise price or tax liability by delivering securities, which is common for equity compensation settlements.

How many Option Care Health (OPCH) shares does Michael Bavaro hold after these transactions?

After the award and the tax-withholding disposition, one transaction line shows 54,002 shares of Option Care Health common stock held directly. Another transaction line lists 44,423 shares following that specific event, reflecting changes at different points in the reporting period.

What role does Michael Bavaro hold at Option Care Health (OPCH) in this Form 4?

Michael Bavaro is identified as an officer of Option Care Health with the title Chief Human Resources Officer. The Form 4 reports his direct beneficial ownership of common stock and details equity award activity and related tax-withholding share dispositions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 08:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bavaro Michael

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		F		551	D	$35.24	44,423	D
Common Stock	02/18/2026		A		9,579(1)	A	$0	54,002	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

	/s/ Michael Bavaro	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.